InflaRx NV buy Lifesci Capital
Start price
05.04.23
/
50%
€5.34
Target price
05.04.24
-
Performance (%)
-73.58%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. The BUY prediction by Lifesci_Capital for InflaRx NV performed very badly with a performance of -73.58%. Lifesci_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InflaRx NV | 17.930% | 17.930% | 13.557% | -75.158% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % | 49,55 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % | 85,97 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % | 63,32 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % | 62,38 % |
Comments by Lifesci_Capital for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Lifesci_Capital gewählte maximale Laufzeit wurde überschritten